Skip to main content
. 2018 Mar 9;23(3):036005. doi: 10.1117/1.JBO.23.3.036005

Fig. 6.

Fig. 6

Real-time evaluation of ischemia-reperfusion model using PAOI. (a) B-mode CRsO2 map at baseline condition (no PBS injection-no IOP increase); a 25-gauge needle is inside the anterior segment of eye. Red and yellow dotted rectangles show the retina and control areas, respectively. The CRsO2 is 68.76±2.34 at baseline (no IOP increase; 10.5±0.33  mmHg). (b) The CRsO2 map 5 s after injection of PBS in the eye. Here, the change in the retina map to blue indicates a decrease in CRsO2 after 5 s of IOP. (c) CRsO2 gradients after injection of PBS (15 s after start of injection). The IOP increased to 46.5±2.54  mmHg, and the CRsO2 decreased to 12.3±3.54. (d) CRsO2 map in reperfusion condition. The imaging plane is different from other three because we had to remove the transducer and measure the IOP with a Tonopen. CRsO2 recovered to 58.87±3.23 after the IOP returned to 16.55±1.67  mmHg. (e) Real-time monitoring of CRsO2 and sO2 using PAOI and pulse oximetry. The Δ shows sO2 difference between baseline and ischemia. (f) Statistical analysis of CRsO2 for five eyes under different conditions including baseline, ischemia, and reperfusion using PAOI. The PAOI shows sixfold decrease in CRsO2 during ischemia (n=5). There was a very significant change between baseline and ischemia and a significant different in CRsO2 from baseline to reperfusion. (g) Statistical analysis of IOP for five eyes at baseline, ischemia, and reperfusion using Tonopen. There is negative correlation between IOP and CRsO2. Error bars shows the standard deviation of five different eyes. Here, * indicates p<0.05 and ** indicates p<0.0001.